Dynavax Technologies Corporation (NASDAQ:DVAX) recovered 473.44% of its value since hitting low of $3.20. The recent move of -9.38% drop pushed the stock to close at $18.35 when trading ended on 11/13/2017. At recent session, the prices were hovering between $18.2 and $20.2129. This company shares are 51.5% off its target price of $27.8 and the current market capitalization stands at $1.1B. The recent change has given its price a -13.52% deficit over SMA 50 and -24.95% deficit over its 52-week high. The stock witnessed -16.21% declines, 13.27% gains and 227.68% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found DVAX’s volatility during a week at 10.6% and during a month it has been found around 7.03%.Dynavax Technologies Corporation (DVAX) Top Holders
Institutional investors currently hold around $752 million or 60.8% in DVAX stock. Look at its top three institutional owners. Federated Investors Inc /Pa/ owns $70.63 million in Dynavax Technologies Corporation, which represents roughly 6.42% of the company’s market cap and approximately 9.39% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 3,134,195 shares of the stock are valued at $63.47 million. The third largest holder is Gmt Capital Corp, which currently holds $61.91 million worth of this stock and that ownership represents nearly 5.63% of its market capitalization.Dynavax Technologies Corporation 13F Filings
At the end of 06/30/2017 reporting period, 68 institutional holders increased their position in Dynavax Technologies Corporation (NASDAQ:DVAX) by some 8,973,849 shares, 40 decreased positions by 4,716,712 and 17 held positions by 23,453,111. That puts total institutional holdings at 37,143,672 shares, according to SEC filings. The stock grabbed 21 new institutional investments totaling 4,052,056 shares while 10 institutional investors sold out their entire positions totaling 1,974,230 shares.Dynavax Technologies Corporation (NASDAQ:DVAX) Insider Trades
Multiple company employees have indulged in significant insider trading. Dynavax Technologies Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Vice President Janssen Robert has acquired 6,000 shares of Dynavax Technologies Corporation (DVAX) in trading session dated Jan. 24, 2017. These shares are worth $24,240 and were traded at $4.04 each. The SEC filing shows that Janssen Robert performed a purchase of 1,452 shares. The Vice President added these shares by way of transaction on Jun. 28, 2016. The company’s shares were assimilated at $13.68 per share worth to an investment of some $19,863 on account of Janssen Robert.
CEO and Director, Gray Eddie, purchased 2,750 common shares of Dynavax Technologies Corporation (DVAX) in the open market. In a transaction dated May. 20, 2016, the shares were bought at an average price of $15.57, giving away a sum of $42,818. After this purchase, 5,250 common shares of DVAX are directly owned by the insider, with total stake valued at $96,338.
In the transaction dated May. 12, 2016, the great number of shares acquired came courtesy the Vice President; Janssen Robert added a total of 1,000 shares at an average price of $15.12, amounting to approximately $15,120. The insider now directly owns 1,000 shares worth $18,350.Dynavax Technologies Corporation (DVAX) Analyst Guide
Several analysts have released their opinion on Dynavax Technologies Corporation (NASDAQ:DVAX), with 4 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.2 average brokerage recommendation.